Pages that link to "Q46234212"

The following pages link to (+)MK-801 does not prevent MPTP-induced loss of nigral neurons in mice. (Q46234212):

Displaying 15 items.

• Evidence for neurogenesis in the adult mammalian substantia nigra (Q24669979) (← links)
• Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration (Q28237641) (← links)
• Macrophage antigen complex-1 mediates reactive microgliosis and progressive dopaminergic neurodegeneration in the MPTP model of Parkinson's disease (Q33112256) (← links)
• Caffeine protects against combined paraquat and maneb-induced dopaminergic neuron degeneration (Q33828847) (← links)
• The effects of age and lipopolysaccharide (LPS)-mediated peripheral inflammation on numbers of central catecholaminergic neurons. (Q35050577) (← links)
• Amantadine protects dopamine neurons by a dual action: reducing activation of microglia and inducing expression of GDNF in astroglia [corrected]. (Q35087517) (← links)
• Animal models of Parkinson's disease progression (Q36924624) (← links)
• Glutamate receptors as therapeutic targets for Parkinson's disease (Q37585401) (← links)
• Targeting glutamate receptors to tackle the pathogenesis, clinical symptoms and levodopa-induced dyskinesia associated with Parkinson's disease (Q38056852) (← links)
• MPTP mouse models of Parkinson's disease: an update (Q38070400) (← links)
• Therapeutic potential of targeting glutamate receptors in Parkinson's disease. (Q38190016) (← links)
• Strategies for the protection of dopaminergic neurons against neurotoxicity. (Q53616687) (← links)
• The neuroprotectant properties of glutamate antagonists and antiglutamatergic drugs (Q79760113) (← links)
• Systemic isradipine treatment diminishes calcium-dependent mitochondrial oxidant stress (Q88511743) (← links)
• Revisiting the Paraquat-Induced Sporadic Parkinson's Disease-Like Model (Q88968501) (← links)